Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-18 4:30 pm Purchase | 2024-12-11 | 13G | AnaptysBio, Inc. ANAB | Fairmount Funds Management LLC | 1,671,484 5.500% | 1,671,484 (New Position) | Filing History |
| 2024-11-14 4:00 pm Purchase | 2024-09-30 | 13G | AnaptysBio, Inc. ANAB | TANG CAPITAL MANAGEMENT LLC | 1,330,879 4.400% | 1,330,879 (New Position) | Filing History |
| 2024-11-14 09:24 am Sale | 2024-09-30 | 13G | AnaptysBio, Inc. ANAB | Deep Track Capital, LP | 0 0.000% | -2,036,990 (Position Closed) | Filing History |
| 2024-08-16 12:07 pm Purchase | 2024-08-14 | 13D | AnaptysBio, Inc. ANAB | EcoR1 Capital, LLC | 7,794,996 25.800% | 274,572 (+3.65%) | Filing History |
| 2024-07-10 10:10 am Purchase | 2024-07-09 | 13G | AnaptysBio, Inc. ANAB | FMR LLC | 2,870,618 10.507% | 2,692,879 (+1515.07%) | Filing History |
| 2024-05-06 12:59 pm Purchase | 2024-04-29 | 13G | AnaptysBio, Inc. ANAB | Frazier Life Sciences Public Fund L.P. | 1,917,191 7.000% | 1,917,191 (New Position) | Filing History |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | AnaptysBio, Inc. ANAB | TANG CAPITAL PARTNERS LP | 1,950,609 7.300% | -678,069 (-25.80%) | Filing History |
| 2024-02-14 10:01 am Sale | 2023-12-31 | 13G | AnaptysBio, Inc. ANAB | Point72 Asset Management, L.P. | 788,545 3.000% | -1,335,655 (-62.88%) | Filing History |
| 2024-02-14 08:35 am Purchase | 2023-12-31 | 13G | AnaptysBio, Inc. ANAB | Deep Track Capital, LP | 2,036,990 7.670% | 676,814 (+49.76%) | Filing History |
| 2024-02-13 4:58 pm Sale | 2023-12-29 | 13G | AnaptysBio, Inc. ANAB | The Vanguard Group - 23-1945930 | 1,380,115 5.190% | -396,793 (-22.33%) | Filing History |
| 2024-01-26 5:25 pm Sale | 2023-12-31 | 13G | AnaptysBio, Inc. ANAB | BlackRock Inc. BLK | 1,799,823 6.800% | -56,443 (-3.04%) | Filing History |
| 2023-10-02 4:32 pm Purchase | 2023-09-22 | 13G | AnaptysBio, Inc. ANAB | Deep Track Capital, LP | 1,360,176 5.120% | 1,360,176 (New Position) | Filing History |
| 2023-02-14 4:21 pm Sale | 2022-12-31 | 13G | AnaptysBio, Inc. ANAB | Point72 Asset Management, L.P. | 2,124,200 7.500% | -157,000 (-6.88%) | Filing History |
| 2023-02-10 09:39 am Sale | 2022-12-31 | 13G | AnaptysBio, Inc. ANAB | James E. Flynn | 1,161,826 4.090% | -304,774 (-20.78%) | Filing History |
| 2023-02-09 11:07 am Sale | 2022-12-30 | 13G | AnaptysBio, Inc. ANAB | The Vanguard Group - 23-1945930 | 1,776,908 6.250% | -65,775 (-3.57%) | Filing History |
| 2023-02-09 10:39 am Sale | 2023-01-31 | 13G | AnaptysBio, Inc. ANAB | FEDERATED HERMES INC. FHI | 1,401,559 4.930% | -971,464 (-40.94%) | Filing History |
| 2023-02-01 09:49 am Purchase | 2022-12-31 | 13G | AnaptysBio, Inc. ANAB | FEDERATED HERMES INC. FHI | 2,373,023 8.350% | 1,053,850 (+79.89%) | Filing History |
| 2023-01-31 5:52 pm Sale | 2022-12-31 | 13G | AnaptysBio, Inc. ANAB | BlackRock Inc. BLK | 1,856,266 6.500% | -9,022 (-0.48%) | Filing History |
| 2022-09-09 4:54 pm Purchase | 2022-08-30 | 13G | AnaptysBio, Inc. ANAB | Point72 Asset Management, L.P. | 2,281,200 8.100% | 2,009,971 (+741.06%) | Filing History |
| 2022-08-15 5:47 pm Purchase | 2022-08-11 | 13G | AnaptysBio, Inc. ANAB | James E. Flynn | 1,466,600 5.190% | 654,116 (+80.51%) | Filing History |